AKRO – akero therapeutics, inc. (US:NASDAQ)
Stock Stats
News
11/20
12:33 pm
akro
Low
Akero Therapeutics Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akero Therapeutics, Inc. - AKRO
11/18
12:20 pm
akro
Low
Halper Sadeh LLC Encourages WOW, AKRO, HFWA, BRY Shareholders to Contact the Firm to Discuss Their Rights
11/12
01:55 pm
akro
Low
Halper Sadeh LLC Encourages NIC, AKRO, BRNS Shareholders to Contact the Firm to Discuss Their Rights
11/12
01:22 pm
akro
Low
Berger Montague PC Investigates Akero Therapeutics, Inc. and Its Board of Directors for Breach of Fiduciary Duties and Violations of Federal Securities Laws (NASDAQ: AKRO)
11/10
06:41 pm
akro
Low
Akero Therapeutics (AKRO): Examining Valuation After Strong Year-to-Date Share Price Gains [Yahoo! Finance]
8/8/2025
07:15 am
akro
-1.9%
BEAT
5/12/2025
07:00 am
akro
0.1%
BEAT
10/11
06:14 am
Downgrades
Strong-Buy
Hold
HC Wainwright
Low
-0.4%
10/10
08:06 am
Reiterates
Outperform
Peer Perform
Wolfe Research
Low
-0.4%
10/10
08:06 am
Reiterates
Outperform
Peer Perform
Wolfe Research
Low
-0.4%
10/10
07:26 am
Downgrades
Outperform
Peer Perform
Wolfe Research
Low
-0.5%
10/10
07:26 am
Downgrades
Outperform
Peer Perform
Wolfe Research
Low
-0.5%
12/3
10:42 am
akro
Low
Form 8-K Akero Therapeutics, Inc. For: Dec 02
11/28
06:04 am
akro
Low
Form 4 Akero Therapeutics, Inc. For: Nov 25 Filed by: Rolph Timothy
11/26
04:04 pm
akro
Low
Form 4 Akero Therapeutics, Inc. For: Nov 24 Filed by: Young Jonathan
11/24
03:48 pm
akro
Low
Form DEFA14A Akero Therapeutics, Inc.
11/21
06:25 pm
akro
Low
Form 4 Akero Therapeutics, Inc. For: Nov 20 Filed by: Cheng Andrew
Show more
Top News Gainers
3/30 Akero Therapeutics to Announce Results for Week 12 Efficacy Endpoints from NASH Phase 2a BALANCED Study of AKR-001 23.4%
4/9 Akero Therapeutics (NASDAQ: AKRO) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 15.2%
3/16 Form 10-K Akero Therapeutics, Inc. For: Dec 31 14.7%
6/19 Form 3 Akero Therapeutics, Inc. For: Jun 19 Filed by: Cheng Andrew 13.4%
4/24 Akero Therapeutics (NASDAQ: AKRO) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $22.00 price target on the stock. 13.1%
6/25 Form 4 Akero Therapeutics, Inc. For: Jun 24 Filed by: Harrison Seth Loring 9.7%
12/19 Form 4 Akero Therapeutics, Inc. For: Dec 17 Filed by: Atlas Venture Fund XI, L.P. 7.6%
6/20 Form 424B4 Akero Therapeutics, Inc. 7.5%
4/13 Akero Therapeutics (NASDAQ: AKRO) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 6.5%
4/7 Akero Therapeutics (NASDAQ: AKRO) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 5.9%
Top News Decliners
3/16 Q4/2019 12/31/2019 EPS -0.550 ZacksConsensus -0.580 ActVsEst 0.030 - Beat -31.4%
1/21 Form 4 Akero Therapeutics, Inc. For: Jan 16 Filed by: Versant Venture Capital VI, L.P. -17.4%
3/18 Akero Therapeutics (NASDAQ: AKRO) had its "buy" rating re-affirmed by analysts at Canaccord Genuity. -14.8%
9/6 Form 8-K Akero Therapeutics, Inc. For: Sep 05 -13.8%
3/6 Form 4 Akero Therapeutics, Inc. For: Mar 04 Filed by: Adelman Robert J -9.7%
12/31 Form 4 Akero Therapeutics, Inc. For: Dec 27 Filed by: Versant Venture Capital VI, L.P. -9.5%
1/2 Form 4 Akero Therapeutics, Inc. For: Dec 31 Filed by: Atlas Venture Fund XI, L.P. -8.7%
3/31 Form 8-K Akero Therapeutics, Inc. For: Mar 31 -7.8%
12/13 Form 4 Akero Therapeutics, Inc. For: Dec 13 Filed by: Rolph Timothy -7.8%
1/14 Form 4 Akero Therapeutics, Inc. For: Jan 13 Filed by: Adelman Robert J -6.0%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3